1.
Antiangiogenic activity of zoledronic acid: inhibition of the VEGF-VEGFR-2 autocrine loop in the endothelial cells of patients with multiple myeloma. Hematol Meeting Rep [Internet]. 2009 Jun. 8 [cited 2025 Jun. 20];2(3). Available from: https://journals.pagepress.org/hmr/article/view/376